Viewing Study NCT02886702


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-03-03 @ 3:09 PM
Study NCT ID: NCT02886702
Status: COMPLETED
Last Update Posted: 2018-08-29
First Post: 2016-08-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Comparing Tazarotene Cream 0.05% to TAZORACĀ® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis
Sponsor: Fougera Pharmaceuticals Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Plaque Psoriasis View
Keywords: